Phathom Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of PHAT for the last quarter is 16.35 M USD, and it's 123.27% higher compared to the previous quarter. The net income of Q3 24 is -85.58 M USD.